Clinical Trials
As an infrastructure at the German Center for Infection Research (DZIF), the Clinical Trial Unit tracks DZIF's study activities in the “Healex Site Management System (SMS)”. Studies are sorted by indication and are continuously updated.
The study register has recently been expanded to include the category “COVID-19”. For the first time, not only DZIF study activities are presented here: In order to provide a comprehensive overview in the current pandemic situation of planned and already active COVID-19 studies in Germany, the Clinical Trial Unit is cooperating with researchers from various German Centers for Health Research and other networks.
For researchers: If your study is not yet included in our portal, please contact the project management of the Clinical Trial Unit.
CoCoNut
- Overall study
- Study Sites (1)
Acronym | ISRCTN | EudraCT | NCT (clinicaltrials.gov) | DRKS |
---|---|---|---|---|
CoCoNut | NCT01821456 |
Cologne Cohort of Neutropenic Patients
Status: Active
Purpose / Objectives
Primary Outcome
Prospective cohort on the outcome of neutropenic patients (risk factors, therapy, treatment results).
Secondary Outcomes
Prospective cohort on the outcome of neutropenic patients (risk factors, therapy, treatment results).
Diagnosis
- Infectious diseases in Hematology and Oncology
- Infectious diseases: Others
- Maligne Tumorerkrankung (English name missing)
Neutropenia
Target population
Inclusion criteria
All patients neutropenic for at least two consecutive days.
Exclusion criteria
none
Study design
- Single center
- Prospective
Documents (password protected)
Responsibilities in overall study
Sponsor
Infektiologie II
- Tel. +49 (0)221 478-85523, -89757
- Fax +49 (0)221 478-85504
- research@uk-koeln.de
Sponsor representative
Univ.-Prof. Dr. med. Oliver A. Cornely
- Tel. +49 221 478-85523
- Fax +49 221 478-1421445
- oliver.cornely@uk-koeln.de
Univ.-Prof. Dr. med. Jörg Janne Vehreschild
- Tel. +49 (0)221 478-88794 / +49 171 6211442
- Fax +49 (0)221 478-85504
- janne.vehreschild@uk-koeln.de
(National) Coordinating Investigator
Univ.-Prof. Dr. med. Jörg Janne Vehreschild
Project management
Infektiologie II
- Tel. +49 (0)221 478-85523, -89757
- Fax +49 (0)221 478-85504
- research@uk-koeln.de
Dr. Sebastian Wingen-Heimann
Data management
Infektiologie II
- Tel. +49 (0)221 478-85523, -89757
- Fax +49 (0)221 478-85504
- research@uk-koeln.de
Dr. Sebastian Wingen-Heimann
Database development
Infektiologie II
- Tel. +49 (0)221 478-85523, -89757
- Fax +49 (0)221 478-85504
- research@uk-koeln.de
Univ.-Prof. Dr. med. Jörg Janne Vehreschild